Evaluation of causes of death among Danish men with initial non-malignant histopathology of the prostate

Q3 Medicine
H.V. Stroomberg , A. Røder , J.T. Helgstrand , K. Brasso , S.B. Larsen
{"title":"Evaluation of causes of death among Danish men with initial non-malignant histopathology of the prostate","authors":"H.V. Stroomberg ,&nbsp;A. Røder ,&nbsp;J.T. Helgstrand ,&nbsp;K. Brasso ,&nbsp;S.B. Larsen","doi":"10.1016/j.jemep.2023.100930","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>The quality of registry-based research depends on the quality of the registered data. The registration of cause of death could be affected by medical history e.g., if cause of death is unclear in a man previously suspected of prostate cancer. Therefore, we assessed the cause of death in men with initial non-malignant prostate biopsy.</p></div><div><h3>Methods</h3><p>From the Danish Prostate Cancer Registry (DaPCaR) men with initial non-malignant biopsies between January 1st, 1995 to December 31st, 2016 who, according to the Danish Register of Cause of Death, subsequently died of prostate cancer (<em>n</em> <!-->=<!--> <!-->964) or other causes (<em>n</em> <!-->=<!--> <!-->9,362) until December 31st, 2019 were identified. All men with prostate cancer death and 1000 randomly selected men who died of other causes, were manually assessed by two experienced urologists. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy were calculated for the Cause of Death registry with the manual assessment as standard.</p></div><div><h3>Results</h3><p>According to manual assessment, 183 men with non-malignant biopsy and subsequent prostate cancer death had metastatic disease at time of non-malignant biopsy and were excluded for further analysis. There was a total of 428 true positives and 353 false positives for prostate cancer-specific death. Moreover, 993 true negatives and 7 false negatives were assessed for other causes of death. The NPV was 99.3% (95%CI: 98.6–99.7), the PPV 54.8% (95%CI: 51.2–58.3), the sensitivity 98.4% (95%CI: 96.7–99.4), the specificity 73.8% (95%CI: 71.3–76.1) and the accuracy 79.8% (95%CI: 77.8–81.6).</p></div><div><h3>Conclusion</h3><p>In men with initial non-malignant biopsy, the cause of death registry is highly reliable in defining who does not die of the disease at the cost of overestimating the disease-specific death. Thus, future registry studies in similar settings should control the cause of death to assure that disease-specific mortality is not inflated.</p></div>","PeriodicalId":37707,"journal":{"name":"Ethics, Medicine and Public Health","volume":"30 ","pages":"Article 100930"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ethics, Medicine and Public Health","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2352552523000610","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 1

Abstract

Background

The quality of registry-based research depends on the quality of the registered data. The registration of cause of death could be affected by medical history e.g., if cause of death is unclear in a man previously suspected of prostate cancer. Therefore, we assessed the cause of death in men with initial non-malignant prostate biopsy.

Methods

From the Danish Prostate Cancer Registry (DaPCaR) men with initial non-malignant biopsies between January 1st, 1995 to December 31st, 2016 who, according to the Danish Register of Cause of Death, subsequently died of prostate cancer (n = 964) or other causes (n = 9,362) until December 31st, 2019 were identified. All men with prostate cancer death and 1000 randomly selected men who died of other causes, were manually assessed by two experienced urologists. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy were calculated for the Cause of Death registry with the manual assessment as standard.

Results

According to manual assessment, 183 men with non-malignant biopsy and subsequent prostate cancer death had metastatic disease at time of non-malignant biopsy and were excluded for further analysis. There was a total of 428 true positives and 353 false positives for prostate cancer-specific death. Moreover, 993 true negatives and 7 false negatives were assessed for other causes of death. The NPV was 99.3% (95%CI: 98.6–99.7), the PPV 54.8% (95%CI: 51.2–58.3), the sensitivity 98.4% (95%CI: 96.7–99.4), the specificity 73.8% (95%CI: 71.3–76.1) and the accuracy 79.8% (95%CI: 77.8–81.6).

Conclusion

In men with initial non-malignant biopsy, the cause of death registry is highly reliable in defining who does not die of the disease at the cost of overestimating the disease-specific death. Thus, future registry studies in similar settings should control the cause of death to assure that disease-specific mortality is not inflated.

初步前列腺非恶性组织病理学的丹麦男性死亡原因评估
背景基于注册的研究的质量取决于注册数据的质量。死亡原因的登记可能会受到病史的影响,例如,如果之前怀疑患有癌症的男性的死亡原因不清楚。因此,我们评估了初次进行非恶性前列腺活检的男性的死亡原因。方法根据丹麦死因登记,从1995年1月1日至2016年12月31日期间首次进行非癌活组织检查的丹麦癌症登记处(DaPCaR)中,确定在2019年12月30日之前死于癌症前列腺癌(n=964)或其他原因(n=9362)的男性。所有前列腺癌症死亡的男性和1000名随机选择的死于其他原因的男性由两名经验丰富的泌尿科医生进行手动评估。以手动评估为标准,计算死因登记的敏感性、特异性、阳性预测值(PPV)、阴性预测值(NPV)和准确性。结果经手工评估,183例前列腺非癌活组织检查及随后的前列腺癌症死亡患者在非癌活组检查时有转移性疾病,排除在外进行进一步分析。前列腺癌特异性死亡共有428例真阳性和353例假阳性。此外,评估了993个真阴性和7个假阴性的其他死因。NPV为99.3%(95%CI:98.6-99.7),PPV为54.8%(95%CI:51.2-58.3),敏感性为98.4%(95%CI:96.7-99.4),特异性为73.8%(95%CI:71.3-76.1),准确性为79.8%(95%CI=77.8-81.6),死亡原因登记在以高估疾病特异性死亡为代价来确定谁没有死于该疾病方面是高度可靠的。因此,未来在类似环境中进行的登记研究应控制死亡原因,以确保特定疾病的死亡率不会被夸大。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Ethics, Medicine and Public Health
Ethics, Medicine and Public Health Medicine-Health Policy
CiteScore
2.20
自引率
0.00%
发文量
107
审稿时长
42 days
期刊介绍: This review aims to compare approaches to medical ethics and bioethics in two forms, Anglo-Saxon (Ethics, Medicine and Public Health) and French (Ethique, Médecine et Politiques Publiques). Thus, in their native languages, the authors will present research on the legitimacy of the practice and appreciation of the consequences of acts towards patients as compared to the limits acceptable by the community, as illustrated by the democratic debate.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信